Merck (NYSE: MRK) and Pfizer (NYSE: PFE) announced the treatment of the first patient in a Phase III study of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE